SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-23-012597
Filing Date
2023-02-17
Accepted
2023-02-17 08:25:38
Documents
2
Period of Report
2023-02-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1600
2 POWER OF ATTORNEY ea173885ex24_jasper.htm EX-24 6107
  Complete submission text file 0001213900-23-012597.txt   9151
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Issuer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1177 AVENUE OF THE AMERICAS, FL 40 NEW YORK NY 10036
Business Address
Kapoor Vishal (Reporting) CIK: 0001798946 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39138 | Film No.: 23640383